Search results
Results from the WOW.Com Content Network
After a secret discount was agreed by Roche the Cancer Drugs Fund will continue to fund it. [27] In June 2017, the NHS Confederation and NHS Chief Executive Simon Stevens announced that the NHS would be offering trastuzumab emtansine to a limited number of women after striking a deal with Roche on the price. [30]
It was named by the Health Service Journal as one of the top hundred NHS trusts to work for in 2015. 92% of staff recommend it as a place for treatment and 73% recommended it as a place to work. [35] In March 2023, it had 1,796 full-time equivalent staff [ 36 ] and a sickness absence rate of 4.7% compared to 4.9% average across England.
The patient's consultant must apply to the fund using an application form supplied by NHS England. Decision Summaries which are the formal decisions of the Chemotherapy Clinical Reference Group are published. [5] Avastin is the most frequently requested treatment. Kadcyla is the most expensive drug funded.
The Sir Bobby Robson Foundation is a British cancer research charity which raises money to fund the early detection and treatment of cancer, and clinical trials of anti-cancer drugs. Based in the North East of England , the Foundation was launched on 25 March 2008 in the name of Sir Bobby Robson , himself a cancer sufferer five times since 1992 ...
Medway NHS Foundation Trust reported that fraudsters stole £500,000, but the majority – £420,000 – was later recovered. ... £19,000 from the fraudulent bank account. As far as we are aware ...
It was named by the Health Service Journal as one of the top hundred NHS trusts to work for in 2015. At that time, it had 7,840 full-time equivalent staff and a sickness absence rate of 4.45%. 70% of staff recommend it as a place for treatment and 52% recommended it as a place to work. [6]
The Velindre University NHS Trust (Welsh: Ymddiriedolaeth GIG Prifysgol Felindre) is an NHS Wales trust established in 1994 as a specialist provider of cancer services in Wales. It runs the Velindre Cancer Centre and the Welsh Blood Service. It also incorporates, on a hosted basis, the NHS Wales Shared Services Partnership (NWSSP).
A number of experimental cancer treatments are continuously under development. In 2023 it was estimated that one in five people will be diagnosed with cancer at some point in their lifetime. [1] The primary goal of cancer treatment is to either cure the cancer by its complete removal, or to considerably prolong the life of the individual.